Are Medical Stocks Lagging DaVita (DVA) This Year?
Here is how DaVita HealthCare (DVA) and Eledon Pharmaceuticals, Inc. (ELDN) have performed compared to their sector so far this year.
Why DaVita HealthCare (DVA) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
DaVita HealthCare (DVA) Registers a Bigger Fall Than the Market: Important Facts to Note
DaVita HealthCare (DVA) closed the most recent trading day at $140.24, moving -1.39% from the previous trading session.
5 Stocks to Gain as Service Side of the Economy Bounces Back
With service sector activity rebounding in recent times, it's worth placing bets on stocks such as CareCloud (CCLD), DaVita (DVA), RadNet (RDNT), SkyWest (SKYW) and American Express (AXP).
Are Investors Undervaluing DaVita (DVA) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the lat...
DaVita Inc. (DVA) Hit a 52 Week High, Can the Run Continue?
DaVita HealthCare (DVA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Ozempic cuts kidney-disease risks, research finds
Novo Nordisk's diabetes drug Ozempic reduces the risk of kidney failure and death in patients who have both Type 2 diabetes and chronic kidney disease, according to new research published Friday in...
Is DaVita (DVA) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the lat...
DaVita (DVA) Gains 34.5% YTD: What's Driving the Stock?
DaVita's (DVA) shares gain on the back of strong fundamentals. However, dependence on commercial payers can be a cause of concern.
4 Must-Buy Momentum Stocks Banking on the Driehaus Strategy
DaVita (DVA), Minerals Technologies (MTX), Alphabet (GOOGL) and Garmin (GRMN) have been selected as the momentum picks for the day using the Driehaus strategy.
4 Stocks to Buy in a Thriving Outpatient Home Health Industry
Despite the macroeconomic challenges, dependence on telehealth and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. DVA, EHC, OPCH and PNTG are well-poi...
Are Medical Stocks Lagging DaVita (DVA) This Year?
Here is how DaVita HealthCare (DVA) and Alcon (ALC) have performed compared to their sector so far this year.
DaVita HealthCare (DVA) is a Top-Ranked Value Stock: Should You Buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
DaVita (DVA) Q1 Earnings & Revenues Top Estimates, Margins Up
DaVita's (DVA) robust segmental revenues drive its first-quarter performance.
DaVita HealthCare (DVA) Surpasses Q1 Earnings and Revenue Estimates
DaVita HealthCare (DVA) came out with quarterly earnings of $2.38 per share, beating the Zacks Consensus Estimate of $1.96 per share. This compares to earnings of $1.58 per share a year ago.
Related Companies